Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome?
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A number of patients with adrenal incidentaloma are exposed to a slight degree of cortisol excess resulting from functional autonomy of the adrenal mass (usually a cortical adenoma). At present, there are only scant data on the unwanted effects of this endocrine condition referred to as subclinical Cushing's syndrome. The aim of the present study was to look for some features of the metabolic syndrome in patients with incidental adrenal adenoma. Forty-one patients (9 men and 32 women) bearing adrenal incidentaloma with typical computed tomography features of cortical adenoma were studied. For both patients and controls, exclusion criteria were age equal to 70 yr or greater, previous history of fasting hyperglycemia, or impaired glucose tolerance (IGT), severe hypertension, current use of medication or concomitant relevant illnesses, and body mass index (BMI) equal to 30 kg/m(2) or greater. Forty-one patients with euthyroid multinodular goiter accurately matched for sex, age, and BMI served for a 1:1 case-control analysis. The study design included an oral glucose tolerance test (75 g) and an endocrine workup aimed at the study of the hypothalamic-pituitary-adrenal axis. Age and BMI were fully comparable between patients (54.0 +/- 10.7 yr, 23.8 +/- 2.4 kg/m(2)) and controls (52.2 +/- 11.6 yr, 23.5 +/- 2.8 kg/m(2)). Fasting glucose and fasting insulin levels were not different between the two groups (4.96 +/- 0.61 mmol/liter vs. 4.88 +/- 0.58 mmol/liter; 67 +/- 34 pmol/liter vs. 59 +/- 32 pmol/liter), but the 2-h postchallenge glucose was significantly higher in patients than in controls (7.43 +/- 2.49 mmol/liter vs. 6.10 plus minus 1.44 mmol/liter, P = 0.01). Fifteen patients (36%) reached the World Health Organization criteria for IGT and two other patients (5%) reached those for diabetes, and 14% of the controls qualified for IGT (P = 0.01). No difference in the lipid pattern was seen between the two groups, but either systolic or diastolic blood pressure were higher in patients (135.4 +/- 15.5 mm Hg vs. 125.0 +/- 15.6 mm Hg, P = 0.003; 82.9 +/- 9.1 mm Hg vs. 75.3 +/- 6.6 mm Hg, P < 0.0001). We calculated the whole-body insulin sensitivity index derived from the oral glucose tolerance test that was significantly reduced in the patients (4.3 +/- 1.7 vs. 5.7 +/- 2.5, P = 0.01). In a multiple regression analysis, 2-h glucose was associated with BMI and midnight cortisol values (r(2) = 0.36, P = 0.002). The comparison of the patients with nonfunctioning adenoma (n = 29) with those with subclinical Cushing's syndrome (n = 12) yielded significant differences as to 2-h glucose and triglyceride levels, which were significantly higher in the second group (7.02 +/- 1.76 mmol/liter vs. 8.72 +/- 3.17 mmol/liter, P = 0.03; 1.06 +/- 0.4 mmol/liter vs. 1.73 +/- 0.96 mmol/liter, P = 0.002), but the insulin sensitivity index was conversely reduced (5.2 +/- 1.4 vs. 2.9 +/- 1.2, P < 0.0001). In conclusion, many patients with incidental adrenal adenoma display altered glucose tolerance, that may be explained by reduced insulin sensitivity, and increased blood pressure levels in comparison with carefully age- and BMI-matched controls. The slight hypercortisolism observed in some such patients may significantly contribute to this state of insulin resistance. Midnight serum cortisol appears as a sensitive marker of the metabolic effects of subclinical Cushing's syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The -mg dexamethasone overnight suppression test is recommended for screening patients with AI for SCS, setting the threshold at nmol/L; a value of nmol/L virtually excludes SCS, whereas values between and nmol/L occupy an area of uncertainty ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [207]
In the citing paper
“Focusing on glucose metabolism, the prevalence of IGT or DM has been higher in patients with SCS than in cases of nonfunctioning adenoma or controls (, , , , , , ), but these data were not confirmed by other studies that found much the same prevalence of these comorbidities in SCS as in the overall series of AI and in the general population (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [207]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 855
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Diagnosing Insulin Resistance in the General Population
McAuley, K. A., Williams, S. M., Mann, J. I., Walker, R. J., Lewis-Barned, N. J., Temple, L. A., & Duncan, A. W. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.460 · Cited by 752
Cited by
Items 301–369 of 369
Approach to Adrenal Incidentalomas: a` review
Imbroll, M. G., Vassallo, J., & Gruppetta, M. (2020) · Malta Medical Journal · Cited by 1
Cushing’s Disease: Diagnostic Evaluation
Findling, J. W., & Raff, H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-264-9_10 · Cited by 1
Glucocorticoids - outcome in patients with glucocorticoid deficiency and Cushing's syndrome
Ragnarsson, Ó. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Síndrome de Cushing subclínico
Salvador, J., gÓmez, F., & Santos, E. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74618-5 · Cited by 1
Incidentalomas suprarrenales. Una enfermedad en auge
Candel, M. F., Flores, B., Albarracín, A., Soria‐Aledo, V., Miguel, J., Campillo, Á., del Pozo, P., Alcaraz, M. G., & Aguayo, J. L. (2006) · Cirugía Española · doi:10.1016/s0009-739x(06)70859-4 · Cited by 1
Ogo, A., Watanabe, A., Ide, C., Maruta, T., Sakai, Y., Hiramatsu, S., Uesugi, N., & Shigematsu, K. (2008) · Institutional Repositories DataBase (IRDB) · doi:10.15017/12487 · Cited by 1
"Diagnóstico e tratamento das massas adrenais clinicamente silenciosas: revisão de literatura"
Sette, M. J. A. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2005.tde-21122005-154758 · Cited by 1
Brossaud, J. (2013) · theses.fr (ABES) · doi:10.70675/43284af6z5f92z45f5z9ff7z7570cc39ffd0 · Cited by 1
Adrenal Incidentalomas and Arterial Hypertension
Παππά, Θ., Kaltsas, G., Piaditis, G. P., & Chrousos, G. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_6
Osteoporosi e ipercortisolismo subclinico
Morelli, V., Palmieri, S., & Chiodini, I. (2011) · L Endocrinologo · doi:10.1007/bf03344854
Functional and diagnostic aspects on adrenocortical adenoma
Enberg, U. (2007) · Figshare
Huntington’s disease : hypothalamic, endocrine and metabolic aspects
Aziz, N. A. (2010) · Leiden Repository (Leiden University)
Hiperfunción de la corteza suprarrenal: síndrome de Cushing
Artero, C. V., de la Vega, M. S., & Asensio, D. P. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70133-2
Masking Effect of Endogenous Hypercortisolism on Vasculitis
Cankurtaran, M., Da??delen, S., Apra, U., Yldz, B. L. O., Kiraz, S., Frat, P., Ertoy, D., & neri, M. A. (2005) · The Endocrinologist · doi:10.1097/01.ten.0000181016.45110.68
11beta-hydroxysteroid dehydrogenase type 1 as a pharmacological target in metabolic disease
Hult, M. (2004) · Figshare
Subklinischer) Hyperkortisolismus als mögliche endokrine Hypertonieursache
Stepan (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Ziaja, J., Chudek, J. T., Król, R., Cierniak, T., Adamczak, M., Więcek, A., & Cierpka, L. (2007) · Polish Journal of Surgery · doi:10.2478/v10035-007-0042-6
Die Diagnose des Cushing-Syndroms
Stepan, & Einleitung, Ñ. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Bilateral adrenal tumors with subclinical hypercortisolemia. To operate or observe
Papierska, L., & Nowak, K. M. (2014) · Postępy Nauk Medycznych
Hypercorticisme infra-clinique : qui explorer et comment ?
Grunenwald, S. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.10.016
TRABAJOS ESPECIALES MANEJO DE PACIENTES CON SÍNDROME DE CUSHING.
Lima-Martínez, M. M., Zerpa, J., Guerrero, Y., Rivera, J., & Vielma, M. (2013)
L'incidentalome surrénalien, étude du statut métabolique et de la fibrinolyse
Thebert, J. (2015) · HAL
Korrelation zwischen Nebennierenmorphologie und kardiovaskulären Parametern
Reincke, M., & Beuschlein, F. (2015)
Adrenale Glucocorticoide und Androgene bei Patienten mit cystischer Fibrose
Wamsler, M. B. (2008) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-1635
General approach to adrenal incidentalomas with regards to a case with subclinical Cushing syndrome
Evran, M., Sert, M., & Tetıker, T. (2016) · Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi) · doi:10.17826/cutf.201860
2. Recent Progress on Clinical Management for Adrenal Disorders.
Nishikawa, T. (2012) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.101.605
Adrenal Incidentaloma and Subclinical Hypercortisolism
Goddard, G. M., & Geer, E. B. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_22
Síndrome de cushing subclínica em incidentalomas adrenais: do desafio do diagnóstico à terapêutica
Fernandes, S. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Kerstens, M. N. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Paroxysmal Hypertension: Pheochromocytoma
Eisenhofer, G., & Lenders, J. W. M. (2017) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_31
Incidentaloma da suprarenal: seguimento clínico, analítico e imagiológico num Centro
Palma, I. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/02pq-m842
Therapy of mild cortisol excess
Iqbal, A., & Newell-Price, J. D. C. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.019
NONFONKSİYONE ADRENAL İNSİDENTALOMALARDA İNSULİN REZİSTANSI VE YENİ İNFLAMATUAR BELİRTEÇLER
Akgün, Z., Güngüneş, A., & Durmaz, Ş. A. (2019) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.611526
Kirnap, N. G., Öztekin, S., & Tütüncü, N. B. (2020) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/dicletip.706119
Factores de riesgo cardiovascular en pacientes con incidentaloma adrenal
Pacheco, N. D., Colete, O. C. M., & Vilar, M. N. (2021) · Acta Médica
Субклінічний гіперкортицизм (огляд літератури та власні спостереження)
Kravchun, N. A., & Полозова, Л. Г. (2014) · Endokrynologia
Cochran-Bührmann, S. (2014) · Online Publication Service of Würzburg University (Würzburg University)
Surrenal Kitle Saptanan Hastaların Klinik, Labaratuar ve Radyolojik Bulguları; Tek Merkez Deneyimi
Tabur, S., Ozturk, S. S., AĞCABAY, O., Akarsu, E., & Araz, M. (2021) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.884977
Den glukokortikoidinduzierten Diabetes auf dem Schirm behalten
Konz, K. (2021) · Info Diabetologie · doi:10.1007/s15034-021-3729-6
Subclinical Cushing’s syndrome: lots of questions — little answers
Rybakov, S. I. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.6.2021.243216
Rojano, N. B., Fernández-Argüeso, M., Botella-Carretero, J. I., Corrales, E. P., & Castro, M. A. (2021) · Research Square · doi:10.21203/rs.3.rs-543785/v1
THE ENDOCRINE SOCIETY 2003 ANNUAL AWARDS
(2003) · Molecular Endocrinology · doi:10.1210/mend.17.8.9642
Emral, R., Aydoğan, B. İ., Köse, A. D., Demir, Ö., & Çorapçıoğlu, D. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.08.005
Is It Relevant to Screen Subclinical Cushing’s Syndrome in Patients With Type 2 Diabetes Mellitus?
Hadiji, M. J., Ksira, I., Haouat, E., Jamoussi, H. K., & Hachmi, L. B. S. (2017) · Journal of Endocrinology and Metabolism · doi:10.14740/jem454w
Nunes, M.-L., & Tabarin, A. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)53091-4
Linos, D. A. (2009) · Springer eBooks · doi:10.1007/978-1-84628-881-4_31
Escribano, P. P. C., Gilabert-González, N., López-Torres, M., Costa-Segovia, R., & Monge, E. A. (2018) · Revista Española de Casos Clínicos en Medicina Interna · doi:10.32818/reccmi.a3s1a10
Case Report: Management of Mild Autonomous Cortisol Secretion
Bammou, S., Ekoundzola, J. R., Rafi, S., Mghari, G. E., & Ansari, N. E. (2023) · SAS Journal of Medicine · doi:10.36347/sasjm.2023.v09i02.007
Subclinical hypercortisolemia – a therapeutic dilemma
Tuszyńska-Meissner, A., & Papierska, L. (2023) · Wiedza Medyczna · doi:10.36553/wm.154
Serfaty, F. M. (2025) · Archives of Endocrinology and Disorders · doi:10.46889/aed.2025.1201
Investigation of outcomes related to adrenal incidentalomas
Patrova, J. (2025) · doi:10.69622/29279696
Das ektope Cushing-Syndrom: Klinik, Diagnostik und Prognose 1990-2012 an der Medizinischen Klinik
Elsishans, A. (2023) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.31671
Leg Edema as a Presenting Sign of Cushing’s Disease
Chow, A., & Heivand, N. (2024) · eScholarship (California Digital Library)
GUIGGI, E. (2019) · Electronic Theses and Dissertations Repository (University of Pisa)
La Síndrome Plurimetabòlica (Síndrome X) com a factor de risc Cardiovascular a l'atencìò primària.
Cabré Vila, J. J. (2004) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Long-Term Follow-Up of Adrenal Incidentalomas: A Portuguese Single-Center Study
Veríssimo, D., Pereira, B., Rodrigues, J., Ivo, C., Martins, A. C., Silva, J. N. E., Passos, D., Lopes, L., de Castro, J. J., & Marcelino, M. (2025) · Endocrinology Insights · doi:10.1159/000543660
ALTINSOY, Ö. (2019) · AYBU AVESIS
Castro, M. A. (2022) · e_Buah
Devaraja, V., Rajoo, S., Valayatham, V. M., & Hui, F. S. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.01.5143
Chongvoranond, P., Chatchomchuan, W., Wanothayaroj, E., Butadej, S., Nakasatien, S., Himathongkam, T., & Thewjitcharoen, Y. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.01.6239
Frequency of Thyroid Nodules and Autoimmune Thyroid Disease in Patients with Adrenal Incidentaloma
Özaşkın, D., Özaşkın, M. O., & Kebapçılar, L. (2025) · Eurasian Journal of Medical Advances · doi:10.14744/ejma.267174
Turan, M., Birgün, M. E., & Güler, S. (2026) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.1906707
Aldahash, R., Alibrahim, A., Samih, M. A., Alkhalaf, M., Alagrafy, N. A., Alqahtani, Y. M. S., & Alqunun, A. (2026) · Journal of Endocrinology and Metabolism · doi:10.14740/jem1656
Wu, B., Tian, X., Fang, C., Han, M., Jin, S., Liu, Q., Zhang, Y., Qiao, Y., & Liu, Y. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.09.004
Sarvi, D. G., Hasani‐Ranjbar, S., Tavassol, Z. H., Ghannadi, S., Ejtahed, H., Najafipour, A., Balagabri, A., & Farsi, F. (2026) · Zahedan Journal of Research in Medical Sciences · doi:10.5812/zjrms-174927
Guller, P. U., Alak, Z. Y. S., Daloğlu, O. O., Ozcan, S. G. G., Güçlü, M., & Kiyici, S. K. (2026) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2978-0435
Metadata
- Authors
- Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., & Angeli, A.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo (IT)
- Corresponding author
- Terzolo, Massimo
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-03
- Volume
- 87
- Issue
- 3
- Pages
- 998-1003
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2109181100
- Cited by
- 322
- References
- 44
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 3 · 2023: 16 · 2022: 9 · 2021: 11 · 2020: 11 · 2019: 9 · 2018: 16 · 2017: 10 · 2016: 7 · 2015: 18 · 2014: 15 · 2013: 16 · 2012: 20
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal incidentaloma, subclinical Cushing's syndrome, metabolic syndrome, adrenal adenoma, impaired glucose tolerance, diabetes mellitus, hypertension, hypothalamic-pituitary-adrenal axis, cortisol excess, oral glucose tolerance test, body mass index, lipid profile, insulin resistance, obesity-related hypertension, obesity-related diabetes
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adult, Aged, Blood Pressure, Cushing Syndrome, Female, Humans, Insulin, Male, Middle Aged, Reference Values, Body Mass Index, Case-Control Studies, Glucose Intolerance, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.